https://www.zacks.com/stock/news/2322230/davita-healthcare-dva-is-up-0-56-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2322230
Aug 14, 2024 - Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-2496604548237961848
0
https://www.zacks.com/stock/news/2322232/ubs-group-ubs-q2-earnings-fall-y-y-on-higher-costs-revenues-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2322232
Aug 14, 2024 - UBS Group's (UBS) second-quarter results reflect growth in asset management, personal & corporate banking and investment bank division. However, a rising expense base is a concern.
zc:1677743969629518295
0
https://www.zacks.com/stock/news/2322172/rogers-communication-rci-sensenet-tie-up-for-new-technology?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2322172
Aug 14, 2024 - Rogers Communication (RCI) collaborates with SenseNet to introduce wildfire detection to 10 communities in Canada.
zc:-394470378020495808
0
https://www.zacks.com/stock/news/2322089/cardinal-health-cah-beats-on-q4-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2322089
Aug 14, 2024 - Cardinal Health's (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
zc:-4125838763060557578
0
https://www.rttnews.com/story.aspx?Id=3468961
Aug 14, 2024 - Shares of UBS Group AG were gaining around 3 percent in the morning trading in Switzerland as well as in pre-market activity on the NYSE after the Swiss banking major reported Wednesday significant growth in second-quarter underlying profit before tax as revenues were benefited mainly by the consolidation of Credit Suisse revenues for the full quarter. Meanwhile, net profit and pre-tax profit...
0
rttnews:2950522727448852475
0
https://www.ocregister.com/2024/08/13/dodgers-walker-buehler-feels-ready-to-live-up-to-standards/
Aug 13, 2024 - Buehler will make his return from the injured list on Wednesday, and he believes he’s in better position to succeed after addressing a hip injury and re-establishing his mechanics.
0
ocr:-5784017593615546809
0
https://seekingalpha.com/news/4139324-raymond-james-ups-ars-to-buy-cites-fda-neffy-approval?source=feed_sector_healthcare
Aug 13, 2024 - Raymond James raises ARS Pharmaceuticals (SPRY) to strong buy, citing FDA approval of its epinephrine nasal spray, neffy. Read more here.
0
sa:-7822676577442887259
0
https://www.zacks.com/stock/news/2321515/pilgrim-s-pride-ppc-is-up-7-72-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2321515
Aug 13, 2024 - Does Pilgrim's Pride (PPC) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:4899823708748590812
0
https://www.zacks.com/stock/news/2321482/abbott-up-7-7-post-q2-earnings-should-you-buy-abt-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2321482
Aug 13, 2024 - Abbott's (ABT) strong growth projection for 2024 is an indication that the stock will be able to sustain the positive momentum through the rest of the year.
zc:-5716674026798734637
0
https://www.zacks.com/stock/news/2321523/4-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-2321523
Aug 13, 2024 - Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, BPOP and LII are some stocks that hold promise.
zc:6879985153947287229
0